No Data
Clearmind Medicine | 6-K: Report of foreign private issuer (related to financial reporting)
Express News | 'Nevada Senators Take Up Resolution Calling On Congress To Reschedule Psychedelics And Streamline Research' - Marijuana Moment
SciSparc Shares Are Soaring Monday: What's Going On?
SciSparc and Clearmine Medicine Shares Are Trading Higher After Announcing Their Collaboration Led to a Patent Application in South Korea for Psychedelic Therapy Targeting Cocaine Addiction.
Express News | SciSparc and Clearmine Medicine Shares Are Trading Higher After Announcing Their Collaboration Led to a Patent Application in South Korea for Psychedelic Therapy Targeting Cocaine Addiction
Clearmind Wins South Korea Patent for Psychedelic Therapy Targeting Cocaine Addiction
